48 related articles for article (PubMed ID: 10208873)
1. Identification of receptor genes in renal cell carcinoma associated with angiogenesis by differential hybridization technique.
Takahashi A; Sasaki H; Kim SJ; Kakizoe T; Miyao N; Sugimura T; Terada M; Tsukamoto T
Biochem Biophys Res Commun; 1999 Apr; 257(3):855-9. PubMed ID: 10208873
[TBL] [Abstract][Full Text] [Related]
2. Analysis of VEGF-responsive genes involved in the activation of endothelial cells.
Wary KK; Thakker GD; Humtsoe JO; Yang J
Mol Cancer; 2003 Jul; 2():25. PubMed ID: 12904264
[TBL] [Abstract][Full Text] [Related]
3. Turning towards nonimmunoreactive tumors: Evaluation of cancer-associated fibroblasts enables prediction of the immune microenvironment and treatment sensitivity in pancreatic cancer.
Lu S; Hua J; Xu J; Wei M; Liang C; Meng Q; Liu J; Zhang B; Wang W; Yu X; Shi S
Comput Struct Biotechnol J; 2022; 20():3911-3923. PubMed ID: 35950187
[TBL] [Abstract][Full Text] [Related]
4. Accelerated growth of hemangioblastoma in pregnancy: the role of proangiogenic factors and upregulation of hypoxia-inducible factor (HIF) in a non-oxygen-dependent pathway.
Laviv Y; Wang JL; Anderson MP; Kasper EM
Neurosurg Rev; 2019 Jun; 42(2):209-226. PubMed ID: 29027018
[TBL] [Abstract][Full Text] [Related]
5. Functional FGFR4 Gly388Arg polymorphism contributes to cancer susceptibility: Evidence from meta-analysis.
Xiong SW; Ma J; Feng F; Fu W; Shu SR; Ma T; Wu C; Liu GC; Zhu J
Oncotarget; 2017 Apr; 8(15):25300-25309. PubMed ID: 28445975
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.
Chen H; Shen DP; Zhang ZZ; Liu JH; Shen YY; Ni XZ
World J Gastroenterol; 2015 Feb; 21(6):1838-44. PubMed ID: 25684949
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of the co-overexpression of fibroblast growth factor receptors 1, 2 and 4 in gastric cancer.
Murase H; Inokuchi M; Takagi Y; Kato K; Kojima K; Sugihara K
Mol Clin Oncol; 2014 Jul; 2(4):509-517. PubMed ID: 24940486
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast growth factor receptor 4 polymorphisms and the prognosis of non-Hodgkin lymphoma.
Cha Z; Zang Y; Guo H; Gu H; Tu X; Song H; Qian B
Mol Biol Rep; 2014 Feb; 41(2):1165-70. PubMed ID: 24381107
[TBL] [Abstract][Full Text] [Related]
9. FGFR4 and TGF-β1 expression in hepatocellular carcinoma: correlation with clinicopathological features and prognosis.
Chen Z; Xie B; Zhu Q; Xia Q; Jiang S; Cao R; Shi L; Qi D; Li X; Cai L
Int J Med Sci; 2013; 10(13):1868-75. PubMed ID: 24324363
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast growth factor receptor 4 polymorphism is associated with increased risk and poor prognosis of non-Hodgkin's lymphoma.
Gao L; Feng Z; Li Q; Li L; Chen L; Xiao T
Tumour Biol; 2014 Apr; 35(4):2997-3002. PubMed ID: 24248544
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast growth factor receptor 4 polymorphisms and coronary artery disease: a case control study.
Zhu Q; Liu T
Mol Biol Rep; 2012 Sep; 39(9):8679-85. PubMed ID: 22696188
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast growth factor receptor 4 polymorphisms and susceptibility to coronary artery disease.
Ma L; Zhang H; Han C; Tong D; Zhang M; Yao Y; Luo Y; Liu X
DNA Cell Biol; 2012 Jun; 31(6):1064-9. PubMed ID: 22313031
[TBL] [Abstract][Full Text] [Related]
13. Tyrosine kinase expression profile in clear cell renal cell carcinoma.
Behbahani TE; Thierse C; Baumann C; Holl D; Bastian PJ; von Ruecker A; Müller SC; Ellinger J; Hauser S
World J Urol; 2012 Aug; 30(4):559-65. PubMed ID: 21969129
[TBL] [Abstract][Full Text] [Related]
14. Perspectives in drug development for metastatic renal cell cancer.
Basu B; Eisen T
Target Oncol; 2010 Jun; 5(2):139-56. PubMed ID: 20689997
[TBL] [Abstract][Full Text] [Related]
15. Endothelial alpha3beta1-integrin represses pathological angiogenesis and sustains endothelial-VEGF.
da Silva RG; Tavora B; Robinson SD; Reynolds LE; Szekeres C; Lamar J; Batista S; Kostourou V; Germain MA; Reynolds AR; Jones DT; Watson AR; Jones JL; Harris A; Hart IR; Iruela-Arispe ML; Dipersio CM; Kreidberg JA; Hodivala-Dilke KM
Am J Pathol; 2010 Sep; 177(3):1534-48. PubMed ID: 20639457
[TBL] [Abstract][Full Text] [Related]
16. Genetic variants in FGFR2 and FGFR4 genes and skin cancer risk in the Nurses' Health Study.
Nan H; Qureshi AA; Hunter DJ; Han J
BMC Cancer; 2009 Jun; 9():172. PubMed ID: 19500394
[TBL] [Abstract][Full Text] [Related]
17. FGFR4 Arg388 allele correlates with tumour thickness and FGFR4 protein expression with survival of melanoma patients.
Streit S; Mestel DS; Schmidt M; Ullrich A; Berking C
Br J Cancer; 2006 Jun; 94(12):1879-86. PubMed ID: 16721364
[TBL] [Abstract][Full Text] [Related]
18. [Microarrays for the identification of molecular markers in the diagnosis and therapy of renal cell carcinomas].
Sültmann H; Poustka A
Urologe A; 2006 Mar; 45(3):297-8, 300-4. PubMed ID: 16465525
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect on expression of angiogenic factors by antiangiogenic agents in renal cell carcinoma.
Sasamura H; Takahashi A; Miyao N; Yanase M; Masumori N; Kitamura H; Itoh N; Tsukamoto T
Br J Cancer; 2002 Mar; 86(5):768-73. PubMed ID: 11875741
[TBL] [Abstract][Full Text] [Related]
20. Identification and classification of differentially expressed genes in renal cell carcinoma by expression profiling on a global human 31,500-element cDNA array.
Boer JM; Huber WK; Sültmann H; Wilmer F; von Heydebreck A; Haas S; Korn B; Gunawan B; Vente A; Füzesi L; Vingron M; Poustka A
Genome Res; 2001 Nov; 11(11):1861-70. PubMed ID: 11691851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
